Gender (number of patients (%)) | ||
Male | 33 | 61% |
Female | 21 | 39% |
Age, years, mean (range) | 44 (17–69) | |
Ethnicity (number of patients (%)) | ||
Asian | 31 | 57% |
Black | 11 | 20.37% |
Not specified | 12 | 22.22% |
Diabetic (number of patients (%)) | 8 | 14.81% |
Site of uveitis (number of patients (%)) | ||
Anterior | 6 (11.11%) | |
Intermediate | 15 (27.78%) | |
Posterior | 12 (22.22%) | |
Panuveitis | 19 (35.19%) | |
Other | 2 (3.70%) | |
Bilateral disease (number of patients (%)) | 41.58(77%) | |
Uveitis features present (NB some patients may have had more than one feature) | ||
Nodular scleritis | 1 | |
Choroiditis | 7 | |
Granulomatous anterior uveitis/ mutton fat KP | 7 | |
Retinal vasculitis | 5 | |
Panuveitis | 13 | |
Intermediate uveitis | 18 | |
Not recorded | 3 | |
Maintenance treatment prior to ATT | Number of patients (%) | |
Unknown | 8 (14.80) | |
Nil | 13 (24.10) | |
Topical steroid alone | 20 (37) | |
Oral steroid alone | 3 (5.60) | |
Oral steroid and immunosuppression | 2 (3.70) | |
Topical steroid and immunosuppression | 1 (1.90) | |
Topical and systemic steroid | 7 (13) |